Online inquiry

IVTScrip™ mRNA-Human ARHGEF33, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK23817MR)

This product GTTS-WK23817MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ARHGEF33 protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001145451.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 100271715
UniProt ID A8MVX0
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGEF33, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK23817MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK14635MR IVTScrip™ mRNA-Human ANKRD66, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD66
GTTS-WK10989MR IVTScrip™ mRNA-Human ADAM12, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ADAM12
GTTS-WK23788MR IVTScrip™ mRNA-Human ARHGAP23, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP23
GTTS-WK14399MR IVTScrip™ mRNA-Human AGGF1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AGGF1
GTTS-WK25400MR IVTScrip™ mRNA-Human ASB8, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ASB8
GTTS-WK27727MR IVTScrip™ mRNA-Human ARID5A, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARID5A
GTTS-WK21512MR IVTScrip™ mRNA-Human ANKRD26P3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD26P3
GTTS-WK12230MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA Additional GABA Compounds
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW